RADNOR,
Pa., Nov. 6, 2024 /PRNewswire/ -- Avantor, Inc.
(NYSE: AVTR), a leading global provider of mission-critical
products and services to customers in the life sciences and
advanced technology industries, announced that the Avantor Board of
Directors has appointed Dame Louise Makin,
DBE, Ph.D., as a director with an initial term expiring at
Avantor's 2025 Annual Meeting of Stockholders. The appointment of
Dame Louise as an independent director fills a vacant board
seat.
Dame Louise brings a wealth of leadership and industry
experience to the Avantor Board. She served as Chief Executive
Officer of BTG plc, an international specialist healthcare company,
for 15 years and led their transformation through organic growth
and acquisitions. The company was acquired by Boston Scientific in
2019. Earlier in her career, she held several leadership positions
at Baxter Healthcare, most recently as
President of Biopharmaceuticals Europe.
"Dame Louise has a proven track record of success in the life
sciences industry, and we are excited to welcome her to the Avantor
Board of Directors," said Jonathan
Peacock, Chairman of the Avantor Board. "Her addition
further demonstrates Avantor's commitment to ensuring we have a
diverse Board, with the right mix of skillsets and experience to
drive innovation across our portfolio, advance our mission, and
create long-term shareholder value."
"It is an honor to join the Avantor Board of Directors, and I
look forward to working closely with the board and executive team
to further strengthen the company's position as a leader in the
life sciences and advanced technologies industries," said Dame
Louise. "Avantor's global reach, innovative products, and services
uniquely position it to drive advancements at every stage of the
scientific journey and deliver differentiated value to its many
stakeholders."
"Dame Louise is an excellent addition to our Board. I welcome
her insights and expertise as we continue to execute our strategic
plan to drive long-term growth and value creation," said
Michael Stubblefield, Avantor
President and Chief Executive Officer.
Dame Louise currently serves as non-executive chair of the Halma
plc Board of Directors and has served as a Non-Executive Director
on the Boards of Premier Foods plc, Intertek Group plc, Woodford
Patient Capital Trust, Atotech Ltd., and Theramex Ltd. She was also
a Trustee of The Outward Bound Trust for 10 years and Chair of the
1851 Trust for five years.
Dame Louise is an Honorary Fellow of St
John's College, Cambridge.
She holds both a master's degree in natural sciences and a Ph.D. in
material sciences from the University of
Cambridge and earned an MBA from The Open University in
Milton Keynes, England. She became
a Dame Commander of the Order of the British Empire in 2014.
About Avantor
Avantor® is a leading
life science tools company and global provider of mission-critical
products and services to the life sciences and advanced technology
industries. We work side-by-side with customers at every step of
the scientific journey to enable breakthroughs in medicine,
healthcare, and technology. Our portfolio is used in virtually
every stage of the most important research, development and
production activities at more than 300,000 customer locations in
180 countries. For more information,
visit avantorsciences.com and find us
on LinkedIn, X
(Twitter) and Facebook.
Global Media Contact
Eric Van Zanten
Head of External
Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com
Investor Relations Contact
Christina Jones
Vice President,
Investor
Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com
View original
content:https://www.prnewswire.com/news-releases/avantor-appoints-dame-louise-makin-dbe-phd-to-its-board-of-directors-302297011.html
SOURCE Avantor and Financial News
